{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:23:54Z","timestamp":1794288234426,"version":"4.9.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 82172727"],"award-info":[{"award-number":["Nos. 82172727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81572459"],"award-info":[{"award-number":["81572459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science Foundation of Beijing","award":["Nos.7202164"],"award-info":[{"award-number":["Nos.7202164"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["No.2021-I2M-1-002"],"award-info":[{"award-number":["No.2021-I2M-1-002"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2023-I2M-2-002"],"award-info":[{"award-number":["2023-I2M-2-002"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-D-001"],"award-info":[{"award-number":["2022-PUMCH-D-001"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-004"],"award-info":[{"award-number":["2022-PUMCH-B-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07164-0","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:28:11Z","timestamp":1760700491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Qiyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangcheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-8460","authenticated-orcid":false,"given":"Ziwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"11","key":"7164_CR1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","volume":"112","author":"AL Blackford","year":"2020","unstructured":"Blackford AL, et al. Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis. J Natl Cancer Inst. 2020;112(11):1162\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"7164_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164(5):752\u201365.","journal-title":"Gastroenterology"},{"issue":"5","key":"7164_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936\u201345.","journal-title":"Ann Surg"},{"issue":"1","key":"7164_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/SLA.0000000000003570","volume":"274","author":"AB Blair","year":"2021","unstructured":"Blair AB, et al. Recurrence in patients achieving pathological complete response after neoadjuvant treatment for advanced pancreatic cancer. Ann Surg. 2021;274(1):162\u20139.","journal-title":"Ann Surg"},{"issue":"3","key":"7164_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1245\/s10434-022-12741-4","volume":"30","author":"I Ogobuiro","year":"2023","unstructured":"Ogobuiro I, et al. Racial disparity in pathologic response following neoadjuvant chemotherapy in resected pancreatic cancer: a multi-institutional analysis from the Central Pancreatic Consortium. Ann Surg Oncol. 2023;30(3):1485\u201394.","journal-title":"Ann Surg Oncol"},{"issue":"32","key":"7164_CR6","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.3748\/wjg.v28.i32.4698","volume":"28","author":"I Ilic","year":"2022","unstructured":"Ilic I, Ilic M. International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: a joinpoint regression analysis. World J Gastroenterol. 2022;28(32):4698\u2013715.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"7164_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/j.gastro.2022.03.011","volume":"163","author":"BZ Huang","year":"2022","unstructured":"Huang BZ, et al. Rising incidence and racial disparities of early-onset pancreatic cancer in the United States, 1995\u20132018. Gastroenterology. 2022;163(1):310-312e1.","journal-title":"Gastroenterology"},{"issue":"1","key":"7164_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cgh.2019.05.059","volume":"18","author":"A Tavakkoli","year":"2020","unstructured":"Tavakkoli A, et al. Racial disparities and trends in pancreatic cancer incidence and mortality in the United States. Clin Gastroenterol Hepatol. 2020;18(1):171\u201317810-e10.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"7164_CR9","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"7164_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/SLA.0000000000003123","volume":"272","author":"KC Honselmann","year":"2020","unstructured":"Honselmann KC, et al. Timing but not patterns of recurrence is different between node-negative and node-positive resected pancreatic cancer. Ann Surg. 2020;272(2):357\u201365.","journal-title":"Ann Surg"},{"issue":"8","key":"7164_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41568-019-0171-3","volume":"19","author":"S Seton-Rogers","year":"2019","unstructured":"Seton-Rogers S. Fibroblasts shape PDAC architecture. Nat Rev Cancer. 2019;19(8):418.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"7164_CR12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"19","key":"7164_CR13","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1158\/1078-0432.CCR-20-5020","volume":"27","author":"RK Nimmakayala","year":"2021","unstructured":"Nimmakayala RK, et al. PGC1alpha-mediated metabolic reprogramming drives the stemness of pancreatic precursor lesions. Clin Cancer Res. 2021;27(19):5415\u201329.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"7164_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","volume":"22","author":"P Sancho","year":"2015","unstructured":"Sancho P, et al. MYC\/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells. Cell Metab. 2015;22(4):590\u2013605.","journal-title":"Cell Metab"},{"issue":"2","key":"7164_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, et al. IL1-induced JAK\/STAT signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9(2):282\u2013301.","journal-title":"Cancer Discov"},{"issue":"8","key":"7164_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17(8):487\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"7164_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110227","volume":"38","author":"ER Murray","year":"2022","unstructured":"Murray ER, et al. Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion. Cell Rep. 2022;38(4):110227.","journal-title":"Cell Rep"},{"issue":"7","key":"7164_CR18","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-18-1955","volume":"25","author":"V Bernard","year":"2019","unstructured":"Bernard V, et al. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res. 2019;25(7):2194\u2013205.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"7164_CR19","first-page":"64","volume":"5","author":"AN Hosein","year":"2019","unstructured":"Hosein AN, et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight. 2019;5(16):64.","journal-title":"JCI Insight"},{"issue":"1","key":"7164_CR20","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","volume":"9","author":"M Bartoschek","year":"2018","unstructured":"Bartoschek M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150.","journal-title":"Nat Commun"},{"issue":"9","key":"7164_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29(9):725\u201338.","journal-title":"Cell Res"},{"issue":"9","key":"7164_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17(9):527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"7164_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3753","volume":"49","author":"OG McDonald","year":"2017","unstructured":"McDonald OG, et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat Genet. 2017;49(3):367\u201376.","journal-title":"Nat Genet"},{"issue":"5","key":"7164_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cmet.2017.04.004","volume":"25","author":"AC Kimmelman","year":"2017","unstructured":"Kimmelman AC, White E. Autophagy and tumor metabolism. Cell Metab. 2017;25(5):1037\u201343.","journal-title":"Cell Metab"},{"key":"7164_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02453","volume":"10","author":"CM Paluskievicz","year":"2019","unstructured":"Paluskievicz CM, et al. T regulatory cells and priming the suppressive tumor microenvironment. Front Immunol. 2019;10:2453.","journal-title":"Front Immunol"},{"key":"7164_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01713","volume":"10","author":"M Schulz","year":"2019","unstructured":"Schulz M, et al. Microenvironmental regulation of tumor progression and therapeutic response in brain metastasis. Front Immunol. 2019;10:1713.","journal-title":"Front Immunol"},{"issue":"3","key":"7164_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"7164_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216095","volume":"558","author":"W Ge","year":"2023","unstructured":"Ge W, et al. PLA2G2A(+) cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8(+) cytotoxic T cells. Cancer Lett. 2023;558:216095.","journal-title":"Cancer Lett"},{"key":"7164_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061399","author":"RS Joshi","year":"2021","unstructured":"Joshi RS, et al. The role of cancer-associated fibroblasts in tumor progression. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13061399.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"7164_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00455-z","volume":"7","author":"EP Storrs","year":"2023","unstructured":"Storrs EP, et al. High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival. NPJ Precis Oncol. 2023;7(1):105.","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"7164_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/2326-6066.CIR-14-0002","volume":"2","author":"DT Fearon","year":"2014","unstructured":"Fearon DT. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance. Cancer Immunol Res. 2014;2(3):187\u201393.","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"7164_CR32","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1053\/j.gastro.2018.12.044","volume":"156","author":"MC Whittle","year":"2019","unstructured":"Whittle MC, Hingorani SR. Fibroblasts in pancreatic ductal adenocarcinoma: biological mechanisms and therapeutic targets. Gastroenterology. 2019;156(7):2085\u201396.","journal-title":"Gastroenterology"},{"issue":"4","key":"7164_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","volume":"19","author":"M Lesina","year":"2011","unstructured":"Lesina M, et al. Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell. 2011;19(4):456\u201369.","journal-title":"Cancer Cell"},{"issue":"4","key":"7164_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","volume":"19","author":"A Fukuda","year":"2011","unstructured":"Fukuda A, et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell. 2011;19(4):441\u201355.","journal-title":"Cancer Cell"},{"key":"7164_CR35","doi-asserted-by":"publisher","first-page":"0050","DOI":"10.34133\/bmr.0050","volume":"28","author":"P Zhou","year":"2024","unstructured":"Zhou P, et al. Targeting reprogrammed cancer-associated fibroblasts with engineered mesenchymal stem cell extracellular vesicles for pancreatic cancer treatment. Biomater Res. 2024;28:0050.","journal-title":"Biomater Res"},{"key":"7164_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914652","author":"A Purushothaman","year":"2023","unstructured":"Purushothaman A, et al. Differential effects of pancreatic cancer-derived extracellular vesicles driving a suppressive environment. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914652.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7164_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84058-3","volume":"11","author":"Y Miyazaki","year":"2021","unstructured":"Miyazaki Y, et al. Adipose-derived mesenchymal stem cells differentiate into heterogeneous cancer-associated fibroblasts in a stroma-rich xenograft model. Sci Rep. 2021;11(1):4690.","journal-title":"Sci Rep"},{"issue":"9","key":"7164_CR38","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-23-1660","volume":"84","author":"S Guinn","year":"2024","unstructured":"Guinn S, et al. Transfer learning reveals cancer-associated fibroblasts are associated with epithelial-mesenchymal transition and inflammation in cancer cells in pancreatic ductal adenocarcinoma. Cancer Res. 2024;84(9):1517\u201333.","journal-title":"Cancer Res"},{"issue":"3","key":"7164_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00441-016-2471-1","volume":"365","author":"Y Mezawa","year":"2016","unstructured":"Mezawa Y, Orimo A. The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas. Cell Tissue Res. 2016;365(3):675\u201389.","journal-title":"Cell Tissue Res"},{"issue":"6","key":"7164_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/ijc.35246","volume":"156","author":"Y Sun","year":"2025","unstructured":"Sun Y, et al. ARP2\/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma. Int J Cancer. 2025;156(6):1272\u201381.","journal-title":"Int J Cancer"},{"issue":"4","key":"7164_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell. 2021;39(4):548\u201365-e6.","journal-title":"Cancer Cell"},{"issue":"6","key":"7164_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccell.2015.11.002","volume":"28","author":"BC Ozdemir","year":"2015","unstructured":"Ozdemir BC, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2015;28(6):831\u20133.","journal-title":"Cancer Cell"},{"issue":"46","key":"7164_CR43","doi-asserted-by":"publisher","first-page":"76197","DOI":"10.18632\/oncotarget.12772","volume":"7","author":"CR Drifka","year":"2016","unstructured":"Drifka CR, et al. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection. Oncotarget. 2016;7(46):76197\u2013213.","journal-title":"Oncotarget"},{"issue":"4","key":"7164_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1084\/jem.135.4.719","volume":"135","author":"G Gabbiani","year":"1972","unstructured":"Gabbiani G, et al. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med. 1972;135(4):719\u201334.","journal-title":"J Exp Med"},{"issue":"5","key":"7164_CR45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4082","volume":"22","author":"H Laklai","year":"2016","unstructured":"Laklai H, et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med. 2016;22(5):497\u2013505.","journal-title":"Nat Med"},{"issue":"3","key":"7164_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","volume":"8","author":"MJ Paszek","year":"2005","unstructured":"Paszek MJ, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241\u201354.","journal-title":"Cancer Cell"},{"key":"7164_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217538","volume":"614","author":"C Quemerais","year":"2025","unstructured":"Quemerais C, et al. Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression. Cancer Lett. 2025;614:217538.","journal-title":"Cancer Lett"},{"issue":"4","key":"7164_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00535-024-02195-8","volume":"60","author":"N Kugiyama","year":"2025","unstructured":"Kugiyama N, et al. Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion. J Gastroenterol. 2025;60(4):479\u201395.","journal-title":"J Gastroenterol"},{"issue":"2","key":"7164_CR49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez CX, et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 2020;10(2):232\u201353.","journal-title":"Cancer Discov"},{"issue":"6","key":"7164_CR50","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","volume":"40","author":"H Huang","year":"2022","unstructured":"Huang H, et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell. 2022;40(6):656-673e7.","journal-title":"Cancer Cell"},{"issue":"6","key":"7164_CR51","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20132000","volume":"211","author":"J Dubrot","year":"2014","unstructured":"Dubrot J, et al. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4(+) T cell tolerance. J Exp Med. 2014;211(6):1153\u201366.","journal-title":"J Exp Med"},{"issue":"4","key":"7164_CR52","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.4049\/jimmunol.1302946","volume":"193","author":"J Abe","year":"2014","unstructured":"Abe J, et al. Lymph node stromal cells negatively regulate antigen-specific CD4+ T cell responses. J Immunol. 2014;193(4):1636\u201344.","journal-title":"J Immunol"},{"issue":"1","key":"7164_CR53","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","volume":"9","author":"MA Lakins","year":"2018","unstructured":"Lakins MA, et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T cells to protect tumour cells. Nat Commun. 2018;9(1):948.","journal-title":"Nat Commun"},{"issue":"8","key":"7164_CR54","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00262-017-2003-1","volume":"66","author":"H Jiang","year":"2017","unstructured":"Jiang H, Hegde S, DeNardo DG. Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. Cancer Immunol Immunother. 2017;66(8):1037\u201348.","journal-title":"Cancer Immunol Immunother"},{"issue":"19","key":"7164_CR55","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-0205","volume":"24","author":"T Kato","year":"2018","unstructured":"Kato T, et al. Cancer-associated fibroblasts affect intratumoral CD8(+) and FoxP3(+) T cells via IL6 in the tumor microenvironment. Clin Cancer Res. 2018;24(19):4820\u201333.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"7164_CR56","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/cas.14346","volume":"111","author":"Y Miyai","year":"2020","unstructured":"Miyai Y, et al. Cancer-associated fibroblasts that restrain cancer progression: hypotheses and perspectives. Cancer Sci. 2020;111(4):1047\u201357.","journal-title":"Cancer Sci"},{"issue":"1","key":"7164_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54975-8","volume":"15","author":"L Veghini","year":"2024","unstructured":"Veghini L, et al. Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer. Nat Commun. 2024;15(1):10534.","journal-title":"Nat Commun"},{"key":"7164_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333638","author":"X Sun","year":"2025","unstructured":"Sun X, et al. Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling. Gut. 2025. https:\/\/doi.org\/10.1136\/gutjnl-2024-333638.","journal-title":"Gut"},{"key":"7164_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342.","journal-title":"Cancer Lett"},{"issue":"10","key":"7164_CR60","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1101\/gad.198630.112","volume":"27","author":"RM Young","year":"2013","unstructured":"Young RM, et al. Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. Genes Dev. 2013;27(10):1115\u201331.","journal-title":"Genes Dev"},{"issue":"22","key":"7164_CR61","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1073\/pnas.1307237110","volume":"110","author":"JJ Kamphorst","year":"2013","unstructured":"Kamphorst JJ, et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci U S A. 2013;110(22):8882\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"7164_CR62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423130122","volume":"122","author":"L Yin","year":"2025","unstructured":"Yin L, et al. The FBXW7-KMT2 axis in cancer-associated fibroblasts controls tumor growth via an epigenetic-paracrine mechanism. Proc Natl Acad Sci U S A. 2025;122(13):e2423130122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"7164_CR63","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/2159-8290.CD-14-1507","volume":"5","author":"B Qiu","year":"2015","unstructured":"Qiu B, et al. HIF2alpha-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 2015;5(6):652\u201367.","journal-title":"Cancer Discov"},{"key":"7164_CR64","doi-asserted-by":"crossref","unstructured":"Ogier C, et al. Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6). bioRxiv; 2023.","DOI":"10.1101\/2023.09.15.557802"},{"issue":"11","key":"7164_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114972","volume":"43","author":"X Han","year":"2024","unstructured":"Han X, et al. Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment. Cell Rep. 2024;43(11):114972.","journal-title":"Cell Rep"},{"issue":"5","key":"7164_CR66","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ccell.2024.04.001","volume":"42","author":"X Chen","year":"2024","unstructured":"Chen X, Huang H. Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts. Cancer Cell. 2024;42(5):744\u20136.","journal-title":"Cancer Cell"},{"issue":"5","key":"7164_CR67","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","volume":"42","author":"N Niu","year":"2024","unstructured":"Niu N, et al. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 2024;42(5):869\u201384-e9.","journal-title":"Cancer Cell"},{"key":"7164_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179369","author":"B Gundel","year":"2024","unstructured":"Gundel B, et al. The crosstalk analysis between mPSCs and Panc1 cells identifies CCN1 as a positive regulator of gemcitabine sensitivity in pancreatic cancer cells. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25179369.","journal-title":"Int J Mol Sci"},{"key":"7164_CR69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146987","author":"S Bhattacharjee","year":"2021","unstructured":"Bhattacharjee S, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI146987.","journal-title":"J Clin Invest"},{"key":"7164_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101807","volume":"38","author":"Z Ye","year":"2021","unstructured":"Ye Z, et al. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biol. 2021;38:101807.","journal-title":"Redox Biol"},{"key":"7164_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi R, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat. 2023;68:100960.","journal-title":"Drug Resist Updat"},{"issue":"21","key":"7164_CR72","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","volume":"136","author":"K Ding","year":"2023","unstructured":"Ding K, et al. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl). 2023;136(21):2521\u201337.","journal-title":"Chin Med J (Engl)"},{"key":"7164_CR73","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao H, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016;5:e10250.","journal-title":"Elife"},{"issue":"7","key":"7164_CR74","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/carcin\/bgu097","volume":"35","author":"CM Sousa","year":"2014","unstructured":"Sousa CM, Kimmelman AC. The complex landscape of pancreatic cancer metabolism. Carcinogenesis. 2014;35(7):1441\u201350.","journal-title":"Carcinogenesis"},{"issue":"5930","key":"7164_CR75","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Van der Heiden","year":"2009","unstructured":"Van der Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"1","key":"7164_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11\u201320.","journal-title":"Cell Metab"},{"key":"7164_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163022","author":"F Kitamura","year":"2023","unstructured":"Kitamura F, et al. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.163022.","journal-title":"JCI Insight"},{"issue":"10","key":"7164_CR78","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/cas.13332","volume":"108","author":"H Kitamura","year":"2017","unstructured":"Kitamura H, et al. Interleukin-6\/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci. 2017;108(10):1947\u201352.","journal-title":"Cancer Sci"},{"issue":"48","key":"7164_CR79","doi-asserted-by":"publisher","first-page":"78396","DOI":"10.18632\/oncotarget.11893","volume":"7","author":"ES Knudsen","year":"2016","unstructured":"Knudsen ES, et al. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential. Oncotarget. 2016;7(48):78396\u2013411.","journal-title":"Oncotarget"},{"issue":"8","key":"7164_CR80","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","volume":"10","author":"D Zhang","year":"2015","unstructured":"Zhang D, et al. Metabolic reprogramming of cancer-associated fibroblasts by IDH3alpha downregulation. Cell Rep. 2015;10(8):1335\u201348.","journal-title":"Cell Rep"},{"issue":"23","key":"7164_CR81","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, et al. The reverse warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009;8(23):3984\u20134001.","journal-title":"Cell Cycle"},{"issue":"1","key":"7164_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07431-4","volume":"16","author":"R He","year":"2025","unstructured":"He R, et al. Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation. Cell Death Dis. 2025;16(1):126.","journal-title":"Cell Death Dis"},{"key":"7164_CR83","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3173","author":"T Li","year":"2025","unstructured":"Li T, et al. Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer. Cancer Res. 2025. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3173.","journal-title":"Cancer Res"},{"issue":"8","key":"7164_CR84","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s43018-022-00426-6","volume":"3","author":"M Yuan","year":"2022","unstructured":"Yuan M, et al. Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth. Nat Cancer. 2022;3(8):945\u201360.","journal-title":"Nat Cancer"},{"issue":"5","key":"7164_CR85","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","volume":"28","author":"M Tajan","year":"2018","unstructured":"Tajan M, et al. A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3. Cell Metab. 2018;28(5):721\u201336-e6.","journal-title":"Cell Metab"},{"key":"7164_CR86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2015.08.003","volume":"43","author":"AL Hsieh","year":"2015","unstructured":"Hsieh AL, et al. MYC and metabolism on the path to cancer. Semin Cell Dev Biol. 2015;43:11\u201321.","journal-title":"Semin Cell Dev Biol"},{"issue":"16","key":"7164_CR87","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig C, et al. The pancreas cancer microenvironment. Clin Cancer Res. 2012;18(16):4266\u201376.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"7164_CR88","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","volume":"75","author":"JJ Kamphorst","year":"2015","unstructured":"Kamphorst JJ, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 2015;75(3):544\u201353.","journal-title":"Cancer Res"},{"issue":"7617","key":"7164_CR89","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature19084","volume":"536","author":"CM Sousa","year":"2016","unstructured":"Sousa CM, et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature. 2016;536(7617):479\u201383.","journal-title":"Nature"},{"issue":"6486","key":"7164_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368(6486):85\u20139.","journal-title":"Science"},{"issue":"4","key":"7164_CR91","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7150\/thno.89805","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, et al. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics. 2024;14(4):1683\u2013700.","journal-title":"Theranostics"},{"issue":"8","key":"7164_CR92","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s42255-020-0226-5","volume":"2","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, et al. Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. Nat Metab. 2020;2(8):775\u201392.","journal-title":"Nat Metab"},{"issue":"3","key":"7164_CR93","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ymthe.2025.01.023","volume":"33","author":"X Liu","year":"2025","unstructured":"Liu X, et al. Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRAS(G12D) protein to cancer-associated fibroblasts. Mol Ther. 2025;33(3):1134\u201353.","journal-title":"Mol Ther"},{"issue":"1","key":"7164_CR94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13046-024-03263-w","volume":"44","author":"C Cencioni","year":"2025","unstructured":"Cencioni C, et al. The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration. J Exp Clin Cancer Res. 2025;44(1):18.","journal-title":"J Exp Clin Cancer Res"},{"issue":"38","key":"7164_CR95","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1073\/pnas.1213353109","volume":"109","author":"T Stylianopoulos","year":"2012","unstructured":"Stylianopoulos T, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012;109(38):15101\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"7164_CR96","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, et al. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"7164_CR97","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6(8):583\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"7693","key":"7164_CR98","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"1","key":"7164_CR99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 2021;7(1):36.","journal-title":"Cell Discov"},{"issue":"2","key":"7164_CR100","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, et al. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell. 2010;17(2):135\u201347.","journal-title":"Cancer Cell"},{"issue":"2","key":"7164_CR101","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccr.2011.06.018","volume":"20","author":"V Sanz-Moreno","year":"2011","unstructured":"Sanz-Moreno V, et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell. 2011;20(2):229\u201345.","journal-title":"Cancer Cell"},{"issue":"10","key":"7164_CR102","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1158\/2159-8290.CD-24-0100","volume":"14","author":"KL Donahue","year":"2024","unstructured":"Donahue KL, et al. Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth. Cancer Discov. 2024;14(10):1964\u201389.","journal-title":"Cancer Discov"},{"issue":"2","key":"7164_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101927","volume":"6","author":"H Li","year":"2025","unstructured":"Li H, et al. Disrupting AGR2\/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Cell Rep Med. 2025;6(2):101927.","journal-title":"Cell Rep Med"},{"issue":"7","key":"7164_CR104","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia CJ, et al. Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment. Gastroenterology. 2022;162(7):2018\u201331.","journal-title":"Gastroenterology"},{"key":"7164_CR105","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009523","author":"N Hansen","year":"2024","unstructured":"Hansen N, et al. Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-009523.","journal-title":"J Immunother Cancer"},{"issue":"50","key":"7164_CR106","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A. 2013;110(50):20212\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"7164_CR107","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910515","volume":"11","author":"H Huang","year":"2019","unstructured":"Huang H, et al. Targeting TGFbetaR2-mutant tumors exposes vulnerabilities to stromal TGFbeta blockade in pancreatic cancer. EMBO Mol Med. 2019;11(11):e10515.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"7164_CR108","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","volume":"145","author":"A Ene-Obong","year":"2013","unstructured":"Ene-Obong A, et al. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology. 2013;145(5):1121\u201332.","journal-title":"Gastroenterology"},{"issue":"7934","key":"7164_CR109","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty AT, et al. Lrrc15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature. 2022;611(7934):148\u201354.","journal-title":"Nature"},{"issue":"1","key":"7164_CR110","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1038\/s41467-024-50441-7","volume":"15","author":"B Assouline","year":"2024","unstructured":"Assouline B, et al. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice. Nat Commun. 2024;15(1):6162.","journal-title":"Nat Commun"},{"issue":"7","key":"7164_CR111","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","volume":"14","author":"JI Belle","year":"2024","unstructured":"Belle JI, et al. Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer. Cancer Discov. 2024;14(7):1324\u201355.","journal-title":"Cancer Discov"},{"issue":"1","key":"7164_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111612","volume":"28","author":"L Liu","year":"2025","unstructured":"Liu L, et al. Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer. iScience. 2025;28(1):111612.","journal-title":"iScience"},{"issue":"6","key":"7164_CR113","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews KM, et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer. Cancer Discov. 2022;12(6):1580\u201397.","journal-title":"Cancer Discov"},{"issue":"1","key":"7164_CR114","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12(1):86.","journal-title":"J Hematol Oncol"},{"key":"7164_CR115","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2013.12.005","volume":"25","author":"J Harper","year":"2014","unstructured":"Harper J, Sainson RC. Regulation of the anti-tumour immune response by cancer-associated fibroblasts. Semin Cancer Biol. 2014;25:69\u201377.","journal-title":"Semin Cancer Biol"},{"key":"7164_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415196","author":"M Tao","year":"2025","unstructured":"Tao M, et al. Transcriptome landscape of cancer-associated fibroblasts in human PDAC. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202415196.","journal-title":"Adv Sci"},{"issue":"3","key":"7164_CR117","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00262-025-03946-z","volume":"74","author":"T Yagi","year":"2025","unstructured":"Yagi T, et al. Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone. Cancer Immunol Immunother. 2025;74(3):96.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"7164_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70126","volume":"39","author":"W Yang","year":"2025","unstructured":"Yang W, et al. Cancer-associated fibroblast-secreted exosomes regulate macrophage polarization in pancreatic cancer via the NOD1 pathway. J Biochem Mol Toxicol. 2025;39(1):e70126.","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"7164_CR119","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir BC, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719\u201334.","journal-title":"Cancer Cell"},{"issue":"12","key":"7164_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin P, et al. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1\u201311.","journal-title":"Exp Mol Med"},{"issue":"12","key":"7164_CR121","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1136\/gutjnl-2024-332371","volume":"73","author":"T Zhou","year":"2024","unstructured":"Zhou T, et al. CD64(+) fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8(+) T cells. Gut. 2024;73(12):1984\u201398.","journal-title":"Gut"},{"issue":"18","key":"7164_CR122","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.7150\/thno.26546","volume":"8","author":"Q Sun","year":"2018","unstructured":"Sun Q, et al. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics. 2018;8(18):5072\u201387.","journal-title":"Theranostics"},{"issue":"7","key":"7164_CR123","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1172\/JCI26532","volume":"116","author":"M Loeffler","year":"2006","unstructured":"Loeffler M. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest. 2006;116(7):1955\u201362.","journal-title":"J Clin Invest"},{"issue":"6165","key":"7164_CR124","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1126\/science.1249481","volume":"342","author":"M McNutt","year":"2013","unstructured":"McNutt M. Cancer immunotherapy. Science. 2013;342(6165):1417.","journal-title":"Science"},{"issue":"15","key":"7164_CR125","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1158\/0008-5472.CAN-13-0062","volume":"73","author":"M Murakami","year":"2013","unstructured":"Murakami M, et al. Docetaxel conjugate nanoparticles that target alpha-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis. Cancer Res. 2013;73(15):4862\u201371.","journal-title":"Cancer Res"},{"issue":"3","key":"7164_CR126","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D Ohlund","year":"2017","unstructured":"Ohlund D, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"22","key":"7164_CR127","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1158\/1078-0432.CCR-24-1004","volume":"30","author":"N Sheng","year":"2024","unstructured":"Sheng N, et al. TAK1 promotes an immunosuppressive tumor microenvironment through cancer-associated fibroblast phenotypic conversion in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2024;30(22):5138\u201353.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"7164_CR128","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1080\/15548627.2023.2300913","volume":"20","author":"X Zhang","year":"2024","unstructured":"Zhang X, et al. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024;20(6):1314\u201334.","journal-title":"Autophagy"},{"issue":"1","key":"7164_CR129","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1038\/s41467-024-49282-1","volume":"15","author":"A Varveri","year":"2024","unstructured":"Varveri A, et al. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development. Nat Commun. 2024;15(1):4988.","journal-title":"Nat Commun"},{"issue":"14","key":"7164_CR130","doi-asserted-by":"publisher","first-page":"13611","DOI":"10.1021\/acsnano.3c02272","volume":"17","author":"S Yuan","year":"2023","unstructured":"Yuan S, et al. Transforming cancer-associated fibroblast barrier into drug depots to boost chemo-immunotherapy in \u201cshooting fish in a barrel\u201d pattern. ACS Nano. 2023;17(14):13611\u201326.","journal-title":"ACS Nano"},{"issue":"7","key":"7164_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12484","volume":"13","author":"H Yao","year":"2024","unstructured":"Yao H, et al. Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer. J Extracell Vesicles. 2024;13(7):e12484.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"7164_CR132","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1158\/2159-8290.CD-17-1371","volume":"8","author":"M Zhang","year":"2018","unstructured":"Zhang M, et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov. 2018;8(8):1006\u201325.","journal-title":"Cancer Discov"},{"key":"7164_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-016-0163-7","volume":"5","author":"S Balaban","year":"2017","unstructured":"Balaban S, et al. Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration. Cancer Metab. 2017;5:1.","journal-title":"Cancer Metab"},{"issue":"11","key":"7164_CR134","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498\u2013503.","journal-title":"Nat Med"},{"issue":"5","key":"7164_CR135","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/2159-8290.CD-18-1212","volume":"9","author":"FR Auciello","year":"2019","unstructured":"Auciello FR, et al. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discov. 2019;9(5):617\u201327.","journal-title":"Cancer Discov"},{"issue":"2","key":"7164_CR136","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1535-7163.MCT-23-0522","volume":"24","author":"F Volat","year":"2025","unstructured":"Volat F, et al. Pancreatic CAF-derived autotaxin drives autocrine CTGF expression to modulate protumorigenic signaling. Mol Cancer Ther. 2025;24(2):230\u201341.","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"7164_CR137","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.cmet.2022.11.003","volume":"34","author":"Z Gong","year":"2022","unstructured":"Gong Z, et al. Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. Cell Metab. 2022;34(12):1960-1976e9.","journal-title":"Cell Metab"},{"issue":"3","key":"7164_CR138","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298\u2013308.","journal-title":"Nat Immunol"},{"issue":"6","key":"7164_CR139","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735\u201347.","journal-title":"Cancer Cell"},{"key":"7164_CR140","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/ncomms3516","volume":"4","author":"VP Chauhan","year":"2013","unstructured":"Chauhan VP, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013;4:2516.","journal-title":"Nat Commun"},{"issue":"3","key":"7164_CR141","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418\u201329.","journal-title":"Cancer Cell"},{"issue":"27","key":"7164_CR142","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem E, et al. Randomized phase III trial of Pegvorhyaluronidase alfa with Nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J Clin Oncol. 2020;38(27):3185\u201394.","journal-title":"J Clin Oncol"},{"issue":"7","key":"7164_CR143","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","volume":"5","author":"JE Murphy","year":"2019","unstructured":"Murphy JE, et al. Total neoadjuvant therapy with FOLFIRINOX in combination with Losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial. JAMA Oncol. 2019;5(7):1020\u20137.","journal-title":"JAMA Oncol"},{"issue":"11","key":"7164_CR144","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1039\/D4TB02206H","volume":"13","author":"G Zhou","year":"2025","unstructured":"Zhou G, et al. A biomimetic dual-targeting nanomedicine for pancreatic cancer therapy. J Mater Chem B. 2025;13(11):3716\u201329.","journal-title":"J Mater Chem B"},{"issue":"10","key":"7164_CR145","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","volume":"119","author":"D Melisi","year":"2018","unstructured":"Melisi D, et al. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. Br J Cancer. 2018;119(10):1208\u201314.","journal-title":"Br J Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07164-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07164-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:03:16Z","timestamp":1760702596000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07164-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7164"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07164-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1118"}}